These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7741886)

  • 1. Toxicity of pentavalent antimony.
    Singh S; Sundar S
    J Assoc Physicians India; 1994 Sep; 42(9):755. PubMed ID: 7741886
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
    Ojha RP; Cervantes D; Fischbach LA
    Clin Infect Dis; 2007 Oct; 45(8):1104; author reply 1005-6. PubMed ID: 17879933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurological toxicity from pentavalent antimonials during the treatment of visceral leishmaniasis].
    Laguna del Estal P; Calabrese S; Zabala JA; Martín T
    Med Clin (Barc); 1994 Feb; 102(7):276-7. PubMed ID: 8170219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of electrocardiographic changes determined by treatment with tri- and pentavalent antimony].
    de Lacerda Júnior FS; Ferminiani H; da Mota CC; Baranski C
    Rev Inst Med Trop Sao Paulo; 1965; 7(4):210-7. PubMed ID: 5854944
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal dysfunction in patients of kala azar treated with sodium antimony gluconate.
    Rai US; Kumar H; Kumar U
    J Assoc Physicians India; 1994 May; 42(5):383. PubMed ID: 7829438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
    de Moura FJ; Leal PP; de Souza Furtado R; Muniz-Junqueira MI; Veiga JP
    Toxicology; 2008 Jan; 243(1-2):66-74. PubMed ID: 18022309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents.
    Kuryshev YA; Wang L; Wible BA; Wan X; Ficker E
    Mol Pharmacol; 2006 Apr; 69(4):1216-25. PubMed ID: 16418337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis.
    Machado PR; Lessa H; Lessa M; Guimarães LH; Bang H; Ho JL; Carvalho EM
    Clin Infect Dis; 2007 Mar; 44(6):788-93. PubMed ID: 17304449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tubular necrosis after non-steroidal anti-inflammatory agents and acute alcoholic intoxication].
    Galzin M; Brunet P; Burtey S; Dussol B; Berland Y
    Nephrologie; 1997; 18(3):113-5. PubMed ID: 9297132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalexin-induced acute tubular necrosis.
    Longstreth KL; Robbins SD; Smavatkul C; Doe NS
    Pharmacotherapy; 2004 Jun; 24(6):808-11. PubMed ID: 15222673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic nephritis during the course of antimony treatment of kala-azar].
    BOUDIN G; PEPIN B; MORIN
    Concours Med; 1957 Jun; 79(24):2927-9. PubMed ID: 13447377
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
    Murray HW
    Acta Trop; 2005 Mar; 93(3):295-301. PubMed ID: 15716043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leishmaniasis].
    Kemp M; Theander TG
    Ugeskr Laeger; 2000 Nov; 162(46):6203-7. PubMed ID: 11107967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alkaloids: future prospective to combat leishmaniasis.
    Mishra BB; Kale RR; Singh RK; Tiwari VK
    Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What did prove useful in the treatment of leishmaniasis].
    Kurban A
    Hautarzt; 1973 Jun; 24(6):271. PubMed ID: 4723879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.